ReviewThe EPMA journal2020
Colorectal cancer in Saudi Arabia as the proof-of-principle model for implementing strategies of predictive, preventive, and personalized medicine in healthcare.
Review in The EPMA journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 50 citations in OpenAlex.
- The prevalence, pathogens, and biochemical determinants of common nosocomial infections among colorectal cancer patients.Journal of family medicine and primary care · 2026Article
- Colorectal Cancer Screening in Saudi Arabia:Saudi medical journal · 2026Review
- Demographics of colonic health: Unveiling sex- and age-driven trends in a cross-sectional retrospective analysis of 2523 colonoscopy procedures.The Journal of international medical research · 2025Article
- Evaluating the implementation of colorectal cancer screening practices at King Abdul-Aziz Medical City, Riyadh.Journal of family medicine and primary care · 2025Article
- Article
- A Comprehensive Systematic Scoping Review of Preventive Medicine and Public Health Systems in Saudi Arabia in the Context of Vision 2030 : Review of Public Health System and Preventive Medicines in Saudi Arabia.Galen medical journal · 2025Article
- IncreasedPharmaceuticals (Basel, Switzerland) · 2024Article
- Insights into Colorectal Cancer Screening Awareness: A Study in the Community of Taif City.Journal of pharmacy & bioallied sciences · 2024Article
- Real-life experiences and barriers to adjuvant chemotherapy in Saudi patients with advanced stage II and stage III colon cancer.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2024Article
- Colorectal cancer's burden attributable to a diet high in processed meat in the Belt and Road Initiative countries.World journal of gastrointestinal oncology · 2024Article
- Article
- Screening, awareness and challenges for colorectal cancer treatment in Saudi Arabia: an update.Bioinformation · 2024Article
- Comprehensive Retrospective Analysis of Colorectal Cancer Incidence Patterns in Saudi Arabia.Life (Basel, Switzerland) · 2023Article
- Article
- Assessment of Psychosocial Correlates and Associated Factors of Colorectal Cancer Screening among Southwestern Saudi Population: A Cross-Sectional Study.Healthcare (Basel, Switzerland) · 2023Article
- Assessing the contribution of nine preventable risk factors attributed to the burden of early onset colorectal cancer in Gulf Cooperation Council (GCC) countries.Preventive medicine reports · 2023Article
- Molecular pathology of colorectal cancer: The Saudi situation in perspective.Saudi medical journal · 2023Review
- Higher Expression Levels ofMedicina (Kaunas, Lithuania) · 2023Article
- The Association between Colorectal Cancer and Colonoscopic Conditions in Saudi Patients: A 10-Year Cross-Sectional-Retrospective Study.Ethiopian journal of health sciences · 2022Article
- The 30-day hospital readmission and mortality after surgery in colorectal cancer patients.BMC gastroenterology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Colorectal cancer (CRC) is the most commonly diagnosed cancer among Saudi males and ranks third in females with up to 73% of cases diagnosed at late stage. This review provides an analysis of CRC situation in the Kingdom of Saudi Arabia (KSA) from healthcare perspective. A PUBMED (1986-2018) search was done to identify publications focusing on CRC in KSA. Due to reports of increased CRC incidence among young age group (< 50), and given the young population of KSA, the disease may burden the national healthcare system in the next decades. Environmental factors attributed to increasing incidence rates of CRC include red meat consumption, sedentary lifestyle, and increased calorie intake. Despite substantial investment in healthcare, attention to predictive diagnostics and targeted prevention is lacking. There is a need to develop national screening guidelines based on evidence that supports a reduction in incidence and mortality of CRC when screening is implemented. Future approaches are discussed based on multi-level diagnostics, risk assessment, and population screening programs focused on the needs of young populations that among others present the contents of the advanced approach by predictive, preventive, and personalized medicine. Recommendations are provided that could help to develop policies at regional and national levels. Countries with demographics and lifestyle similar to KSA may gain insights from this review to shape their policies and procedures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.